Expert consensus is a crucial guiding document in the field of medicine. It can quickly grasp and reflect the latest progress in this field, especially on clinical issues that have not yet been clarified in scientific research, and provide important reference for doctors 'clinical practice.

In my country, stem cell therapy, as an emerging medical method, has received widespread attention in recent years and achieved remarkable research results.

To this end, my country has issued a number of expert consensuses on stem cell therapy, providing clear guidance and reference for the clinical application of stem cells.

The following is a brief summary of the existing expert consensus on stem cell therapy in my country:

1. Guidelines for Standardization of Stem Cell Anti-Aging Technology (2016)

Published by the Anti-Aging Branch of China Plastic and Cosmetic Association, it provides detailed regulations on the implementation organization, personnel qualifications, equipment requirements, operating procedures, quality control and complication management of stem cell anti-aging technology.

2. China Expert Consensus on Aging and Anti-Aging (2019)

The consensus, published by the journal Geriatrics and Health Care, mentioned that anti-aging strategies include eliminating aging cells, taking drugs, restricting diet, interfering with intestinal flora, and replenishing stem cells and active factors.

3. Expert Consensus on Standardizing Autologous Stem Cell Transplantation for the Treatment of Chronic Ischemic Diseases of the Lower Limbs (2021)

The consensus was jointly issued by a statement by multiple institutions including the Stem Cell Engineering Professional Committee under the Medical Engineering Branch of the Chinese Medical Association. The safety and effectiveness of autologous stem cell transplantation in the treatment of chronic ischemic diseases of the lower limbs have been achieved. The general recognition of the academic community indicates that this treatment method has great potential and broad prospects in clinical application.

4. Expert Consensus on Standardized Stem Cell Transplantation for the Treatment of Decompensated Liver Cirrhosis (2021)

The consensus was demonstrated by experts from the Stem Cell Engineering Group of the Medical Engineering Branch of the Chinese Medical Association. The consensus includes the clinical application specifications and research priorities of stem cell transplantation in the treatment of decompensated cirrhosis.

5. Consensus of China Experts on the Diagnosis and Treatment of Chronic Graft-versus-Host Disease (cGVHD)(2021)

This consensus provides a detailed guiding framework for the diagnosis and treatment of cGVHD, points out that mesenchymal stem cells have shown good application potential in the prevention and treatment of cGVHD, and emphasizes the key to early accurate diagnosis and standardized treatment, with a view to improving patients 'long-term quality of life.

6. Expert Consensus on Clinical Drug Treatment of Osteoarthritis (2021)

The consensus was released by the Sports Medical Branch of the Chinese Medical Association and other institutions, mentioning the potential of mesenchymal stem cells in the treatment of osteoarthritis. Although their clinical efficacy and safety still need to be verified by a large number of randomized controlled trials, it is important for osteoarthritis. Treatment provides new possibilities.

7. Expert Consensus on Mesenchymal Stem Cells for the Treatment of Novel Coronavirus Pneumonia (2021)

The consensus was jointly issued by the National Center for Clinical Medicine of Infectious Diseases and other authoritative organizations as a guidance on the treatment of COVID-19 with mesenchymal stem cells. The content includes patient screening criteria, preparations before cell infusion, and monitoring during the treatment process. Measures and treatment methods for adverse reactions and other aspects.

8. Expert Consensus on Research and Clinical Trials of Stem Cells in the Field of Plastic, Restorative and Cosmetics (2021)

The consensus was released by the Stem Cell and Regenerative Medicine Group of the Plastic and Cosmetic Physicians Branch of the China Medical Doctor Association, emphasizing that stem cells and their derivative products have been used in many fields such as skin regeneration, tissue repair, blood vessel formation, soft tissue and osteochondral regeneration, tissue anti-aging and hair follicle regeneration. It has demonstrated excellent therapeutic effects.

The consensus also clearly pointed out that autologous stem cell transplantation has been widely recognized by the academic community in the treatment of chronic ischemic diseases of the lower limbs, and its safety and effectiveness have been verified. Autologous stem cell transplantation has demonstrated significant clinical benefits by inducing new angiogenesis, improving ischemic conditions, alleviating related symptoms, promoting ulcer healing, preventing amputation, and improving overall prognosis.

9. China Expert Consensus on Autologous Stem Cell Transplantation for Heart Failure (2022)

The consensus was released by the Heart Regeneration Group of the Tissue Repair and Regeneration Branch of the Chinese Medical Association. It focused on elaborating key technical issues related to the process of autologous stem cell transplantation and put forward future research directions for autologous stem cell transplantation for the treatment of cardiovascular diseases. Suggestions.

10. Expert Consensus on Allogeneic Mesenchymal Stem Cells for the Treatment of Systemic Lupus Erythematis (2022)

The consensus was released by the Rheumatology Branch of the Chinese Medical Association and the Professional Committee for Clinical New Technology Application of China Hospital Association. It clearly stated that many clinical studies have confirmed that mesenchymal stem cells are safe and effective in treating patients with systemic lupus erythematosus.

11. Expert Consensus on Stem Cell Therapy for Psoriasis (Psoriasis) Trial (2024)

The world's first expert consensus on stem cell treatment for psoriasis, led by my country, clearly defines the types of stem cells commonly used in psoriasis treatment, treatment methods, required doses and routes of administration, and establishes standards for clinical evaluation (including efficacy evaluation and safety considerations), providing innovative treatment options for psoriasis patients.

12. Consensus of China Experts on the Diagnosis and Treatment of Chronic Graft-versus-Host Disease (cGVHD)(2024 Edition)

This consensus updates multiple key diagnosis and treatment links such as diagnosis, prevention, treatment, prognosis assessment and quality of life assessment. The consensus puts forward a number of update highlights in the prevention and treatment of cGVHD. There is more evidence-based medical evidence in the prevention of cGVHD than in the treatment of hormone-resistant cGVHD.

13. Consensus of China geriatric experts on anti-aging drug intervention (2024)

The consensus was initiated by the Geriatrics Branch of the Chinese Medical Association and emphasized the potential of stem cell therapy in anti-aging. It is pointed out that stem cell therapy can replenish regenerative cells, improve frail symptoms in the elderly, and reduce inflammation levels. Infusion of mesenchymal stem cells (MSCs) from bone marrow can enhance the physical fitness of aging and frail patients, such as increasing walking distance and improving cognition and physical functions. The consensus also mentioned that anti-aging strategies include supplementing stem cells and active factors. By injecting cells or active factors, it is possible to reduce the harm of aging and improve the health of middle-aged and elderly people.

These expert consensus on stem cell therapy issued by my country provide important guidance and reference for the clinical application of stem cells and promote the continuous development and progress in the field of stem cell therapy.